The role of plasmapheresis in the multimodal treatment of anti-Pr cold agglutinin disease

Authors

  • Melissa Cushing,

    1. From The New York-Presbyterian Hospital-Weill Cornell Medical College, New York, New York; the Division of Transfusion Medicine and Cellular Therapy, New York Presbyterian Hospital-Weill Cornell Medical Campus, New York, New York; and the Laboratory of Immunohematology, New York Blood Center, Long Island City, New York.
    Search for more papers by this author
  • Diana Degtyaryova,

    1. From The New York-Presbyterian Hospital-Weill Cornell Medical College, New York, New York; the Division of Transfusion Medicine and Cellular Therapy, New York Presbyterian Hospital-Weill Cornell Medical Campus, New York, New York; and the Laboratory of Immunohematology, New York Blood Center, Long Island City, New York.
    Search for more papers by this author
  • Christine Lomas-Francis

    1. From The New York-Presbyterian Hospital-Weill Cornell Medical College, New York, New York; the Division of Transfusion Medicine and Cellular Therapy, New York Presbyterian Hospital-Weill Cornell Medical Campus, New York, New York; and the Laboratory of Immunohematology, New York Blood Center, Long Island City, New York.
    Search for more papers by this author

Melissa Cushing, MD, The New York-Presbyterian Hospital-Weill Cornell Medical College, 525 E. 68th St, Box 251, NY 10065; e-mail: mec2013@med.cornell.edu.

No abstract is available for this article.

Ancillary